BOS Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$344K Hold
509
– – 0.08% 147
2026
Q2
$255K Sell
509
-60
-11% -$28.8K 0.06% 170
2026
Q1
$280K Buy
569
+40
+8% +$21.7K 0.07% 163
2025
Q4
$307K Sell
529
-18
-3% -$10.2K 0.08% 149
2025
Q3
$265K Hold
547
– – 0.07% 156
2025
Q2
$222K Buy
+547
New +$229K 0.07% 161
2024
Q4
– Sell
-330
Closed -$204K – 174
2024
Q3
$204K Buy
+330
New +$195K 0.08% 161
2023
Q1
– Sell
-397
Closed -$219K – 128
2022
Q4
$219K Buy
+397
New +$210K 0.2% 112

Other funds holding TMO

BOS Asset Management's TMO Position: Q3 2026 in Review

BOS Asset Management held its Thermo Fisher Scientific (TMO) position steady in Q3 2026 at 509 shares worth $344K. The position accounts for 0.08% of the portfolio, ranked #147.

BOS Asset Management first reported a position in TMO in Q4 2022 and has held it in 8 quarters since. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • BOS Asset Management held 509 shares of Thermo Fisher Scientific worth $344K as of Q3 2026.
  • BOS Asset Management left its Thermo Fisher Scientific share count unchanged in Q3 2026.
  • Thermo Fisher Scientific made up 0.08% of BOS Asset Management's portfolio in Q3 2026, its #147 holding.
  • BOS Asset Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 8 quarters since.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on BOS Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.